Winaid-P Tablet is a combination analgesic and antipyretic medication containing Nimesulide 100 mg and Paracetamol 325 mg. Nimesulide, a selective cyclooxygenase-2 (COX-2) inhibitor, provides effective anti-inflammatory, analgesic, and antipyretic effects by reducing the synthesis of prostaglandins involved in pain and inflammation. Paracetamol, a widely used analgesic and antipyretic agent, acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. The synergistic action of these two components makes Winaid-P effective in managing acute pain conditions such as musculoskeletal pain, dental pain, postoperative pain, and primary dysmenorrhea, as well as fever associated with various infections. Winaid-P is generally well tolerated; however, it should be used with caution in patients with hepatic or renal impairment, and prolonged use should be avoided to minimize potential adverse effects. It is contraindicated in individuals with known hypersensitivity to either component, active peptic ulcer, or severe hepatic dysfunction. Winaid-P should be administered as directed by a healthcare professional, with attention to dosing intervals to prevent overdose. This combination offers a balanced approach to pain and fever management, optimizing therapeutic efficacy while minimizing side effects.